Small LDL and its clinical importance as a new CAD risk factor: a female case study
- PMID: 12417832
- DOI: 10.1111/j.0889-7204.2002.01453.x
Small LDL and its clinical importance as a new CAD risk factor: a female case study
Abstract
The underlying metabolic cause of coronary heart disease in many patients is not high blood cholesterol. In fact, the Framingham study has reported that 80% of individuals who go on to have coronary artery disease have the same total blood cholesterol values as those who do not go on to have a cardiovascular event. The most common metabolic contributor to coronary artery disease is the atherogenic lipoprotein profile, characterized by an abundance of highly atherogenic small, dense low-density lipoprotein particles and a deficiency of the high-density lipoprotein (HDL) subtype most associated with coronary artery disease protection (HDL(2b)). This trait is present in 50% of men with coronary artery disease and is not reflected by total or low-density lipoprotein cholesterol values. While fasting triglycerides tend to he higher, and HDL cholesterol lower in patients with the atherogenic lipoprotein profile, the majority have triglyceride and HDL cholesterol values generally accepted to be in the "normal" range. An abundance of basic science and clinical trial evidence convincingly indicates that the presence of an atherogenic lipoprotein profile signifies a three-fold increased risk for a cardiovascular event and rapid arteriographic progression, but it also identifies a group of patients who respond particularly well to specific therapeutic interventions. Often the most effective interventions are the least expensive.
Copyright 2002 CHF, Inc.
Similar articles
-
Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.Physiol Res. 2001;50(1):1-8. Physiol Res. 2001. PMID: 11300220
-
[Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes].Medicina (Kaunas). 2005;41(11):925-31. Medicina (Kaunas). 2005. PMID: 16333215 Lithuanian.
-
Triglyceride as a risk factor for coronary artery disease.Am J Cardiol. 1998 Nov 5;82(9A):22Q-25Q. doi: 10.1016/s0002-9149(98)00770-x. Am J Cardiol. 1998. PMID: 9819100 Review.
-
HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.Neuro Endocrinol Lett. 2011;32(4):502-9. Neuro Endocrinol Lett. 2011. PMID: 21876506 Clinical Trial.
-
Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.Am J Cardiol. 1998 Feb 26;81(4A):18B-25B. doi: 10.1016/s0002-9149(98)00033-2. Am J Cardiol. 1998. PMID: 9526809 Review.
Cited by
-
LDL Subclasses in Ischemic Stroke: A Risk Factor?Noro Psikiyatr Ars. 2019 Mar;56(1):13-17. doi: 10.5152/npa.2017.19393. Epub 2018 Jul 5. Noro Psikiyatr Ars. 2019. PMID: 30911231 Free PMC article.
-
New Advances in Rapid Pretreatment for Small Dense LDL Cholesterol Measurement Using Shear Horizontal Surface Acoustic Wave (SH-SAW) Technology.Int J Mol Sci. 2024 Jan 15;25(2):1044. doi: 10.3390/ijms25021044. Int J Mol Sci. 2024. PMID: 38256117 Free PMC article.
-
Dietary fatty acids and inflammatory markers in patients with coronary artery disease.Adv Biomed Res. 2014 Jul 31;3:148. doi: 10.4103/2277-9175.137818. eCollection 2014. Adv Biomed Res. 2014. PMID: 25221751 Free PMC article.
-
Saturated Fat: Part of a Healthy Diet.Curr Nutr Rep. 2018 Sep;7(3):85-96. doi: 10.1007/s13668-018-0238-x. Curr Nutr Rep. 2018. PMID: 30084105 Review.
-
Deleterious effects of potassium bromate administration on renal and hepatic tissues of Swiss mice.Saudi J Biol Sci. 2018 Feb;25(2):278-284. doi: 10.1016/j.sjbs.2017.01.060. Epub 2017 Jan 31. Saudi J Biol Sci. 2018. PMID: 29472778 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous